Dr. Consolacion Melguizo is a full professor at the
Department of Anatomy and Embryology at the University of Granada, sub-director
of the Biomedical Research Center (CIBM) from Granada, and Director of the
Master of Regenerative Biomedicine at the University of Granada. She is a
member of the CT-107 Group of Junta de Andalucia. Her research activity in the
field of basic oncology began in 1991. During these 29 years, her research has
focused on cancer, specifically on the development of new therapeutic strategies
based on nanomedicine, gene therapy, and resistance to anticancer drugs. She
has participated in 16 research contracts with companies in the biomedical area
and in 50 research projects of which he has led IP 20. She has also developed
13 patents related to new cancer therapeutic strategies. This work has allowed
her to carry out regular and intense research, producing numerous publications,
book chapters, communications to conferences, etc., that have allowed her to
obtain five six-year periods of research and one six-year period of transfer.
Her teaching disciplines include Human Anatomy, Regenerative Biomedicine, and
DNA Technology, among others. She has been awarded seven research awards, among
which is the I Health Research Award of the Andalusian Autonomous Community.
She has been the director or co-director of 20 doctoral theses, most of them
with international quality mention.
Short Biography
Dr. Consolacion Melguizo is a full professor at the
Department of Anatomy and Embryology at the University of Granada, sub-director
of the Biomedical Research Center (CIBM) from Granada, and Director of the
Master of Regenerative Biomedicine at the University of Granada. She is a
member of the CT-107 Group of Junta de Andalucia. Her research activity in the
field of basic oncology began in 1991. During these 29 years, her research has
focused on cancer, specifically on the development of new therapeutic strategies
based on nanomedicine, gene therapy, and resistance to anticancer drugs. She
has participated in 16 research contracts with companies in the biomedical area
and in 50 research projects of which he has led IP 20. She has also developed
13 patents related to new cancer therapeutic strategies. This work has allowed
her to carry out regular and intense research, producing numerous publications,
book chapters, communications to conferences, etc., that have allowed her to
obtain five six-year periods of research and one six-year period of transfer.
Her teaching disciplines include Human Anatomy, Regenerative Biomedicine, and
DNA Technology, among others. She has been awarded seven research awards, among
which is the I Health Research Award of the Andalusian Autonomous Community.
She has been the director or co-director of 20 doctoral theses, most of them
with international quality mention.